Anti-CEACAM5/CEA/CD66e Antibody (CergutuzumAb)
Catalog No.
F1696
Anti-CEACAM5/CEA/CD66e Antibody (CergutuzumAb)
Featured Products
Cergutuzumab (Anti-CEACAM5 / CEA / CD66e) is a humanized monoclonal antibody targeting carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) with immunostimulatory and anti-tumor activities. Molecular weight: 146.48 KD.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
146.48 kDa
Dry ice
1509916-03-3
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
GA504, CEA-IL2v
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P06731
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human CEACAM5 / CEA / CD66e his at 2 ug/mL can bind Anti-CEACAM5/CEA/CD66e Antibody (CergutuzumAb)
CEACAM5 / CEA / CD66e
Please avoid freeze-thaw cycles.